CoChat

Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline

Open access
Freda, Pamela U., Beckers, Albert M., Katznelson, Laurence, Molitch, Mark E., Montori, Victor M., Post, Kalmon D., Vance, Mary Lee · 2011 · The Journal of Clinical Endocrinology & Metabolism
Cited by 585

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Objective: The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus Process: Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-person meeting. Conclusions: We recommend that patients with a pituitary incidentaloma undergo a complete history and physical examination, laboratory evaluations screening for hormone hypersecretion and for hypopituitarism, and a visual field examination if the lesion abuts the optic nerves or chiasm. We recommend that patients with incidentalomas not meeting criteria for surgical removal be followed with clinical assessments, neuroimaging (magnetic resonance imaging at 6 months for macroincidentalomas, 1 yr for a microincidentaloma, and thereafter progressively less frequently if unchanged in size), visual field examinations for incidentalomas that abut or compress the optic nerve and chiasm (6 months and yearly), and endocrine testing for macroincidentalomas (6 months and yearly) after the initial evaluations. We recommend that patients with a pituitary incidentaloma be referred for surgery if they have a visual field deficit; signs of compression by the tumor leading to other visual abnormalities, such as ophthalmoplegia, or neurological compromise due to compression by the lesion; a lesion abutting the optic nerves or chiasm; pituitary apoplexy with visual disturbance; or if the incidentaloma is a hypersecreting tumor other than a prolactinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-1048

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 10

  1. Fernandez-Balsells, 2010, The natural history of pituitary incidentalomas: a systematic review and meta-analysis, J Clin Endocrinol Metab
  2. Freda, 1999, Differential diagnosis of sellar masses., Endocrinol Metab Clin North Am, 28, 81, 10.1016/S0889-8529(05)70058-X · doi:10.1016/s0889-8529(05)70058-x
  3. Black, 1987, Hormone production in clinically nonfunctioning pituitary adenomas., J Neurosurg, 66, 244, 10.3171/jns.1987.66.2.0244 · doi:10.3171/jns.1987.66.2.0244
  4. Esiri, 1983, Pituitary adenomas: immunohistology and ultrastructural analysis of 118 tumors., Acta Neuropathol, 62, 1, 10.1007/BF00684914 · doi:10.1007/bf00684914
  5. Al-Shraim, 2006, The 2004 World Health Organization classification of pituitary tumors: what is new?, Acta Neuropathol, 111, 1, 10.1007/s00401-005-1093-6 · doi:10.1007/s00401-005-1093-6
  6. Karavitaki, 2007, Silent corticotroph adenomas., Arq Bras Endocrinol Metabol, 51, 1314, 10.1590/S0004-27302007000800017 · doi:10.1590/s0004-27302007000800017
  7. Greenman, 2005, Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth., Clin Endocrinol (Oxf), 63, 39, 10.1111/j.1365-2265.2005.02295.x · doi:10.1111/j.1365-2265.2005.02295.x
  8. Lohmann, 2001, Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline., Pituitary, 4, 173, 10.1023/A:1015366923810 · doi:10.1023/a:1015366923810
  9. Merola, 1993, Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas., Horm Res, 40, 149, 10.1159/000183785 · doi:10.1159/000183785
  10. de Bruin, 1992, Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro., J Clin Endocrinol Metab, 75, 1310

Cited by

Metadata

Authors
Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-04-01
Volume
96
Issue
4
Pages
894-904
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2127738340
Cited by
585
References
42
FWCI
21.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.